HPL Stock Overview
Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Hoechst Pakistan Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | PK₨1,399.99 |
| 52 Week High | PK₨1,422.00 |
| 52 Week Low | PK₨650.00 |
| Beta | 0.37 |
| 1 Month Change | 3.41% |
| 3 Month Change | 6.06% |
| 1 Year Change | 100.00% |
| 3 Year Change | 64.86% |
| 5 Year Change | 76.32% |
| Change since IPO | 974.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| HPL | PK Pharmaceuticals | PK Market | |
|---|---|---|---|
| 7D | 3.7% | 2.1% | 1.0% |
| 1Y | 100.0% | 38.1% | 58.1% |
Return vs Industry: HPL exceeded the PK Pharmaceuticals industry which returned 36.3% over the past year.
Return vs Market: HPL exceeded the PK Market which returned 56.9% over the past year.
Price Volatility
| HPL volatility | |
|---|---|
| HPL Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in PK Market | 8.4% |
| 10% least volatile stocks in PK Market | 3.3% |
Stable Share Price: HPL has not had significant price volatility in the past 3 months.
Volatility Over Time: HPL's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of PK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 734 | Sajjad Iftikhar | www.hoechst.com.pk |
Hoechst Pakistan Limited engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company provides its antibiotic, cardiology, diabetes, pain and allergy, and other products under Flagyl, Clexane, NO-SPA, Lantus, Amaryl, Claforan, Haemaccel, Enterogermina, and Plavix brands. It also offers various shampoos under the Selsun Blue brand name.
Hoechst Pakistan Limited Fundamentals Summary
| HPL fundamental statistics | |
|---|---|
| Market cap | PK₨13.50b |
| Earnings (TTM) | PK₨360.81m |
| Revenue (TTM) | PK₨21.37b |
37.4x
P/E Ratio0.6x
P/S RatioIs HPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HPL income statement (TTM) | |
|---|---|
| Revenue | PK₨21.37b |
| Cost of Revenue | PK₨15.84b |
| Gross Profit | PK₨5.53b |
| Other Expenses | PK₨5.17b |
| Earnings | PK₨360.81m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 37.41 |
| Gross Margin | 25.86% |
| Net Profit Margin | 1.69% |
| Debt/Equity Ratio | 0% |
How did HPL perform over the long term?
See historical performance and comparison